SavedAdd your journal

Journals / Turkish Journal of Health Science and Life / 2025 / Cilt: 8 Sayı: 3

The Effect of Anxiety Levels of Patients with Respiratory Diseases on Their Attitudes Towards Complementary Therapies During The COVID-19 Pandemic Period

COVID-19 Pandemi Sürecinde Göğüs Hastalarının Anksiyete Düzeylerinin Tamamlayıcı Terapilere Yönelik Tutumlarına Etkisi

Sibel Şentürk(Mehmet Akif Ersoy Üniversitesi Bucak Sağlık Yüksekokulu)0000-0002-5634-174X
Alev Yildirim Keskin(Selçuk Üniversitesi Akşehir Kadir Yallagöz Sağlık Yüksekokulu)0000-0003-0981-5364
Şule Sarızayim(Department of Emergency, Adana 5 Ocak Public Hospital)0000-0003-0172-0985
Pages
123–136
Publication Date
2025-12-31
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that 43.5% of the patients had a respiratory system disorder for 6-10 years and 46.0% had bronchitis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: This study aims to determine the effect of anxiety levels of patients with respiratory diseases on their attitudes towards complementary therapies during the COVID-19 pandemic period.
📊
Key Findings & Data:Material and Method: This descriptive cross-sectional study was included with 352 chest patients.
💡
Conclusion & Impact:It was found that 43.5% of the patients had a respiratory system disorder for 6-10 years and 46.0% had bronchitis.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Göğüs hastası · anksiyete · tamamlayıcı tedavi

Abstract

Aim: This study aims to determine the effect of anxiety levels of patients with respiratory diseases on their attitudes towards complementary therapies during the COVID-19 pandemic period. Material and Method: This descriptive cross-sectional study was included with 352 chest patients. Data were collected using the "Patient Information Form" developed by the researchers, the Coronavirus Anxiety Scale (C19P-S), and the Attitude Towards Complementary Therapies Scale (ACTS). Statistical analyses were performed using descriptive statistics, the Mann-Whitney U test, the Kruskal-Wallis test, and the Spearman Correlation test. Results: The total scores of the patients with respiratory diseases were 0.67±1.06 on the C19P-S Scale and 16.40±4.60 on the ACTS Scale. It was found that 43.5% of the patients had a respiratory system disorder for 6-10 years and 46.0% had bronchitis. It was determined that patients with respiratory disease frequently experienced shortness of breath and the alternative treatment method they utilized to prevent attacks was 86.9% herbal treatment method. In the study, a significant relationship was determined between the mean scores of the ACTS and the mean scores of the C19P-S (p<0.05). Conclusion: The study found that patients experiencing higher levels of anxiety showed an increased use of complementary methods during the pandemic. It is observed that health policies are necessary to promote the development of accurate attitudes towards the utilization of complementary methods as well as interventions to reduce the anxiety of patients with respiratory diseases.

Özet

Amaç: Bu çalışmanın amacı COVID-19 pandemi sürecinde göğüs hastalarının anksiyete düzeylerinin tamamlayıcı tedavilere yönelik tutumlarına olan etkisini belirlemektir. Gereç ve Yöntem: Tanımlayıcı kesitsel tipteki bu çalışmaya 352 göğüs hastası dahil edildi. Veriler, araştırmacılar tarafından geliştirilen "Hasta Bilgi Formu", Koronavirüs Anksiyete Ölçeği (KAÖ) ve Tamamlayıcı Tedavilere Yönelik Tutum Ölçeği (TTYTÖ) kullanılarak toplandı. İstatistiksel analizler, tanımlayıcı istatistikler, Mann-Whitney U testi, Kruskal-Wallis testi ve Spearman Korelasyon testi kullanılarak yapıldı. Bulgular: Göğüs hastalarının KAÖ Ölçeği'ne göre toplam puanları 0,67±1,06, TTYTÖ Ölçeği'ne göre ise 16,40±4,60 olarak bulundu. Hastaların %43,5'inin 6-10 yıldır solunum sistemi rahatsızlığı olduğu, %46,0'ının ise bronşit olduğu belirlendi. Göğüs hastalığı olan hastaların sıklıkla nefes darlığı yaşadığı ve atakları önlemek için başvurdukları alternatif tedavi yönteminin %86,9'unun bitkisel tedavi yöntemi olduğu belirlendi. Çalışmada TTYTÖ puan ortalamaları ile KAÖ puan ortalamaları arasında anlamlı bir ilişki saptandı (p<0,05). Sonuç: Çalışma, yüksek düzeyde anksiyete yaşayan hastaların pandemi döneminde tamamlayıcı yöntemleri daha fazla kullandığını ortaya koymuştur. Tamamlayıcı yöntemlerin kullanımına yönelik doğru tutumların geliştirilmesini ve göğüs hastalarının anksiyetesini azaltmaya yönelik müdahalelerin teşvik edilmesi için sağlık politikalarının gerekli olduğu görülmektedir.

🔖

Cite This Article

Şentürk, S., Keskin, A. Y., Sarızayim, Ş. (2025). The Effect of Anxiety Levels of Patients with Respiratory Diseases on Their Attitudes Towards Complementary Therapies During The COVID-19 Pandemic Period. Turkish Journal of Health Science and Life, Cilt: 8 Sayı: 3, 123–136. https://doi.org/10.56150/tjhsl.1808153

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (69)

  1. WHO. Coronavirus disease (COVID-19) pandemic. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. (Accessed June 18, 2025).
  2. Boer de M. G., Houweling L., Hendriks R., Vercoulen H. J., Stranders-Tramper A. G., & Braunstahl J. G. Asthma patients experience increased symptoms of anxiety, depression and fear during the COVID-19 pandemic. Chronic Respiratory Disease, 18, (2021), 1–7. https://doi.org/10.1177/14799731211029658.
  3. Fakılı F., & Bayram N. Anxiety levels, sleep quality and follow-up of obstructive sleep apnoea patients during the COVID-19 pandemic. The Journal of Turkish Sleep Medicine, 9, (2022), 147-152. https://doi.org/10.4274/jtsm.galenos.2021.76476.
  4. Efil S., & Enç N. Effects of COVID-19 on respiratory system and nursing care. Journal of Intensive Care Nursing, 25(2), (2021), 79-91. https://dergipark.org.tr/tr/pub/ybhd/issue/64661/892850.
  5. Singh D., Mathioudakis G. A., & Higham A. Chronic obstructive pulmonary disease and COVID-19: interrelationships. Current Opinion in Pulmonary Medicine, 28(2), (2022), 76–83. https://doi.org/10.1097/mcp.0000000000000834.
  6. Sykes D. L., Faruqi S., Holdsworth L., & Crooks M. G. Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient's perspective, ERJ Open Research, 7(1), (2021), 00822-2020. https://doi.org/10.1183/23120541.00822-2020.
  7. McAuley H., Hadley K., Elneima O., Brightling C. E., Evans R. A., Steiner M. C., & Greening N. J. COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD. ERJ Open Research, 7(1), (2021), 00718-2020. https://doi.org/10.1183/23120541.00718-2020.
  8. Pleguezuelos E., Carmen Del A., Moreno E., Ortega P., Vila X., Ovejero L., &.Miravitlles M. The experience of COPD patients in lockdown due to the COVID-19 pandemic. International Journal of Chronic Obstructive Pulmonary Disease, 15, (2020), 2621-2627. https://doi.org/10.2147/copd.s268421.
  9. Karaca A., Kaya L., Beyazay S., & Kaya Z. The effect of anxiety and fear experienced in individuals with chronic diseases on self-care management during the COVID-19 pandemic. Archives of Health Science and Research, 9(3), (2022), 169-174. https://doi.org/10.5152/ArcHealthSciRes.2022.22030.
  10. Wang Y, Shi C, Yang Y, Zhang S, Li W, Huang N, et al. Anxiety and depression in allergic rhinitis patients during COVID-19 pandemic in Wuhan, China. Asian Pacific Journal of Allergy and Immunology, 40(3), (2022), 210-216.
  11. Çelik Y. M., Sungur M., & Geçici F. Alternative medicine methods applied to their children by mothers with fear of COVID-19. Health Academy Kastamonu, 7(COVID 19-Suppl Issue), (2022), 28-37. https://doi.org/10.25279/sak.1090870.
  12. Delibaş L., Polat F., & Çakıcı A. E. Adults' state of using complementary and alternative medicine during the COVID-19 pandemic: Complementary and alternative medicine during the COVID-19 pandemic. Holistic Nursing Practice, 39(1), (2025), 59-65. https://doi.org/10.1097/hnp.0000000000000506.
  13. Arslan G., & Mollaoğlu M. Evaluation of the relationship between the adherence to the treatments of individuals with chronic obstructive pulmonary disease and their attitudes towards complementary and alternative medicine in the COVID-19 pandemic. International Journal of Clinical Images and Medical Reviews, 2(5), (2022), 1-5. https://dx.doi.org/10.55920/IJCIMR.2022.02.001094.
  14. Karaman Özlü Z., Kilinç T., Özlü İ., Ünal H., & Toraman R. L. The relationship between individuals' use of complementary and alternative medicine during the pandemic in Turkey and their attitudes towards perceived COVID-19 risk. European Journal of Integrative Medicine, 56, (2022), 102194. https://doi.org/10.1016/j.eujim.2022.102194.
  15. Parzavi M. M., Forouhari S., Shahriarirad R., Shahriarirad S., Bradley D. R., & Roosta L. Prevalence and associated factors of complementary and integrative medicine use in patients afflicted with COVID-19. BMC Complementary Medicine and Therapies, 22(1), (2022), 251. https://doi.org/10.1186/s12906-022-03722-x.
  16. Nural N., & Çakmak S. Status of using complementary and alternative treatments of individuals with chronic disease. Journal of Traditional Medical Complementary Therapies, 1, (2018), 1-9. https://doi.org/10.5336/JTRACOM.2017-54818.
  17. Muz G., Erat A., Şamdanlı Ş., & Bayrak Y. N. Use of integrative medicines by chronic obstructive pulmonary disease patients and its relation with hopelessness levels. Çukurova Medical Journal, 45(4), (2020), 1598-1606. https://doi.org/10.17826/cumj.742875.
  18. Kaya Y., Bostan S., Kaya A., Karaman Ö., Karataş A., & Dereli S. Effect of COVID-19 pandemic on anxiety depression and intention to go to hospital in chronic patients. International Journal of Clinical Practice, 75(7), (2021), e14219. https://doi.org/10.1111/ijcp.14219.
  19. Sheha S. D., Rehim-Abdel S. A., Latif-Abdel O. M., Abdelkader M. A., Raafat R. H., Sallam S. A., & Mostafa N. S. Level of asthma control and mental health of asthma patients during lockdown for COVID-19: a cross-sectional survey. The Egyptian Journal of Bronchology, 15(1), (2021), 12. https://doi.org/10.1186/s43168-021-00058-x.
  20. Lee S. A. Coronavirus anxiety scale: a brief mental health screener for COVID-19 related anxiety. Death Studies, 44(7), (2020), 393–401. https://doi.org/10.1080/07481187.2020.1748481.
  21. Biçer İ., Çakmak C., Demir H., & Kurt M. E. Coronavirus anxiety scale short form: Turkish validity and reliability study. Anatolian Clinic the Journal of Medical Sciences, 25(1), (2020), 216-225. https://doi.org/10.21673/anadoluklin.731092.
  22. Bilge A., Uğuryol M., Dülgerler Ş., & Yıldız M. Developing of attitude towards using complementary scales. Journal of Ege University Nursing Faculty, 34(2), (2018), 55-63. https://dergipark.org.tr/tr/pub/egehemsire/issue/38978/417299.
  23. Kaplan M. COVID-19: Traditional and complementary healing practices in the pandemic process. Milli Folklor, 32(6), (2020), 35-45. https://dergipark.org.tr/tr/pub/millifolklor/issue/56908/772153.
  24. Günaydın N. C., & Baykal S. Evaluation of anxiety level during COVID-19 pandemic in adolescences with asthma. Namık Kemal Medicine Journal, 8(3), (2020), 288-294. https://doi.org/10.37696/nkmj.771013.
  25. Calgni N., Gana K., & Beşlisi B. A systematic review of complementary and alternative medicine in oncology: psychological and physical effects of manipulative and body-based practices. PLoS One, 14(10), (2019), e0223564. https://doi.org/10.1371/journal.pone.0223564.
  26. Hu R., Lin C., Xu W., Liu Y., & Long C. Ethnobotanical study on medicinal plants used by Mulam people in Guangxi, China. Journal of Ethnobiology and Ethnomedicine, 40, (2020), 1-50. https://doi.org/10.1186/s13002-020-00387-z.
  27. Khadka D., Dhamala K. M., Li F., Aryal P. C., Magar P. R., Bhatta S., &. Cui D. The use of medicinal plants to prevent COVID-19 in Nepal. Journal of Ethnobiology and Ethnomedicine, 26, (2021), 1-17. https://doi.org/10.21203/rs.3.rs-88908/v2.
  28. Mulder L. T. C., Busch M., Kristoffersen A. E., Nordberg J. H., & van der Werf E. T. Prevalence and predictive factors of complementary medicine use during the first wave of the COVID-19 pandemic of 2020 in the Netherlands. BMC Complementary Medicine and Therapies, 43, (2022), 1-10. https://doi.org/10.1186/s12906-022-03528-x.
  29. Tejada-Villena M., Ferchau-Vera I., Cardona-Rivero A., Zamalloa-Cornejo R., Quispe-Florez M., Frisancho-Triveno Z., &.Yanez J. A. Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: a cross-sectional survey. PLoS One, 16(9), (2021), e0257165. https://doi.org/10.1371/journal.pone.0257165.
  30. De Sousa J. A., Silva Y. S., Roque F., da Costa Fernandes S. D., & Delgado M. N. Use of medicinal plants and socioeconomic evaluation of urban and rural populations of Sobradinho (DF-Brazil). Revista Agrogeoambiental, 12(1), (2020), 50–63. https://doi.org/10.18406/2316-1817v12n120201416.
  31. Güven Ş. D., Muz G., Efe Ertürk N., & Özcan A. Use of complementary and alternative treatment in the patients with hypertension. Balıkesir Health Sciences Journal, 2(3), (2013), 160-166. https://doi.org/10.5505/bsbd.2013.02996.
  32. Kretchy I. A., Boadu J. A., Kretchy J-P., Agyabeng K., Passah A. A., Koduah A., & Opuni K. F. M. Utilization of complementary and alternative medicine for the prevention of COVID-19 infection in Ghana: A national cross-sectional online survey. Preventive Medicine Reports, 24, (2021), 101633. https://doi.org/10.1016/j.pmedr.2021.101633.
  33. Aslan H., Çetkin T., & Demir Dikmen R. Effects of chronic illness adaptation on the healthy lifestyle behaviours of patients in internal services. Cukurova Medical Journal, 46(3), (2021), 1140-1149. https://doi.org/10.17826/cumj.913997.
  34. Ogbu C. E., Oparanma C. A., & Kirby R. S. Factors associated with the use of complementary and alternative medicine/therapy among United States adults with asthma. Healthcare, 11(7), (2023), 983. https://doi.org/10.3390/healthcare11070983.
  35. Kaplan Serin E., Türkben Polat H., & Çevik Durmaz Y. Attitudes of patients with chronic obstructive pulmonary disease about complementary alternative medicine. Journal of General Health Sciences, 4(3), (2022), 288-296. https://dergipark.org.tr/en/pub/jgehes/issue/74149/1057607.
  36. Kılıç B., Çınar F. I., Akkoç G., & Arslan Y. Evaluation of complementary and alternative medicine practices use in patients with chronic obstructive pulmonary disease: assessment of beliefs and medication adherence. International Journal of Caring Sciences, 17(1), (2024), 527-536.
  37. Sylvain B., Barbara B., Jean-Michel G., & Thierry F-C. Complementary and alternative medicines in patients with alcohol or tobacco use disorder: use, expectations and beliefs. European Journal of Integrative Medicine, 51(Suppl 2), (2022), 102115. https://doi.org/10.1016/j.eujim.2022.102115.
  38. Cheng F. K. Analysing the use of acupuncture in smoking cessation. Addicta: The Turkish Journal on Addictions, 6(2), (2019), 283-313. https://doi.org/10.15805/addicta.2019.6.2.0017.
  39. Aljawadi M. H., Khoja A. T., AlOtaibi A. D., Alharbi K. T., Alodayni M. A., AlMetwazi M. S., & Khoja T. A. The utilization of complementary and alternative medicine among Saudi older adults: a population-based study. Evidence-Based Complementary and Alternative Medicine, 1, (2020), 1-14. https://doi.org/10.1155/2020/4357194.
  40. Lee SA, Crunck EA. Fear and psychopathology during the COVID-19 crisis: Neuroticism, hypochondriasis, reassurance-seeking, and coronaphobia as fear factors. OMEGA (Westport), 85(2), (2022), 483-496. https://doi.org/10.1177/0030222820949350.
  41. Cekic Y., Uslu Sahan F., & Er Korucu A. The Effect of Fear of COVID-19 experienced by married individuals living in Türkiye on marital adjustment. Eurasian Journal of Family Medicine, 12(1), (2023), 22-30. https://doi.org/10.33880/ejfm.2023120103.
  42. Luo F., Ghanei Gheshlagh R., Dalvand S., Saedmoucheshi S., & Li Q. Systematic review and meta-analysis of fear of COVID-19. Frontiers in Psychology, 12, (2021), 661078. https://doi.org/10.3389/fpsyg.2021.661078.
  43. Kolakowsky-Hayner S. A., Goldin Y., Kingsley K., Alzueta E., Arango-Lasprilla J. C., Perrin P. B., &.Constantinidou F. Psychosocial impacts of the COVID-19 quarantine: a study of gender differences in 59 countries. Medicina, 57(8), (2021), 789. https://doi.org/10.3390/medicina57080789.
  44. Aksoy A, Abiç A, Değirmenci F, Vefikuluçay Yılmaz D. The relationship between quality of life and fear of Turkish individuals during the COVID-19 pandemic: a cross-sectional study. Archives of Psychiatric Nursing, 35(5), (2021), 472-478. https://doi.org/10.1016/j.apnu.2021.06.003.
  45. Cori L., Curzio O., Adorni F., Prinelli F., Noale M., Trevisan C., &. Bianchi F. Fear of COVID-19 for individuals and family members: indications from the national cross-sectional study of the EPICOVID19 web-based survey. Int J Environ Res Public Health, 18(6), (2021), 3248. https://doi.org/10.3390/ijerph18063248.
  46. Milman E., Lee S. A., & Neimeyer R. A. Social isolation and the mitigation of coronavirus anxiety: the mediating role of meaning. Death Studies, 46(1), (2022), 1-13. https://doi.org/10.1080/07481187.2020.1775362.
  47. Sahu T. People with chronic bronchitis are at more risk of getting COVID-19. ECS Transactions, 107(1), (2022), 16359-16368. https://doi.org/10.1149/10701.16359ecst.
  48. Philip K. E. J., Buttery S., Williams P., Vijayakumar B., Tonkin J., Cumella A., &. Hopkinson N. S. Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey. BMJ Open Respiratory Research, 9(1), (2022), e001056. https://doi.org/10.1136/bmjresp-2021-001056.
  49. Huyut T. M., & Soygüder S. The multi-relationship structure between some symptoms and features seen during the new Coronavirus 19 infection and the levels of anxiety and depression post-COVID. Eastern Journal of Medicine, 27(1), (2022), 1-10. https://dx.doi.org/10.5505/ejm.2022.35336.
  50. Pupo-Pedrozo C. J., & Arias-Campo A. Depression, perceived stress related to COVID, post-traumatic stress, and insomnia among asthma and COPD patients during the COVID-19 pandemic. Chronic Respiratory Disease, 17, (2020), 1479973120962800. https://doi.org/10.1177/1479973120962800.
  51. Mark D. J., & Chung Y. Complementary and alternative medicine in pulmonology. Current Opinion in Pediatrics, 27(3), (2015), 334-340. https://doi.org/10.1097/mop.0000000000000217.
  52. Atıcı E., Doymaz F., Kendal K., Gülşen M., & Dan E. M. The effects of yoga on the health profile, depression and anxiety levels of the individuals during the COVID-19 pandemic process: a randomize trial. Journal of Traditional Medical Complementary Therapies, 4(3), (2021), 369-375. https://doi.org/10.5336/jtracom.2021-82688.
  53. Seifert G., Jeitler M., Stange R., Michalsen A., Cramer H., Brinkhaus B., &. Kessler C. S. The relevance of complementary and integrative medicine in the COVID-19 pandemic: a qualitative review of the literature. Frontiers Medicine, 7, (2020), 1-14. https://doi.org/10.3389/fmed.2020.587749.
  54. Erfani A, Shahriarirad R, Ranjbar K, Mirahmadizadeh A, Moghadami M. Knowledge, attitude and practice toward the novel coronavirus (COVID-19) outbreak: a population-based survey in Iran. Journal of Health Sciences and Surveillance System, 11, (2023), 578-591. https://doi.org/10.30476/jhsss.2022.94639.1550.
  55. Reel J. J., Campbell H., Kerr J. G., & Sinclair S. M. Complementary therapies for chronic obstructive pulmonary disease. Journal of Community Medicine & Health Education, 6, (2016), e125. https://doi.org/10.4172/2161-0711.1000e125.
  56. Badakhsh M., Dastras M., Sarchahi Z., Doostkami M., Mir A., & Bouya S. Complementary and alternative medicine therapies and COVID-19: a systematic review. Reviews on Environmental Health, 36(3), (2021), 443-450. https://doi.org/10.1515/reveh-2021-0012.
  57. Siddiq B. A. Md., Rathore A. F., Clegg D., & Rasker J. J. Pulmonary rehabilitation in COVID-19 patients: a scoping review of current practice and its application during the pandemic. Turkish Journal of Physical Medicine and Rehabilitation, 66(4), (2020), 480–494. https://doi.org/10.5606/tftrd.2020.6889.
  58. Anllo H., Herer B., Delignieres A., Ghergan A., Bocahu Y., Segundo I., &. Larue F. Hypnosis for the management of COPD-related anxiety and dyspnoea in pulmonary rehabilitation: rationale and design for a cluster-randomised, active-control trial. ERJ Open Research, 8(1), (2021), 00565-2021. https://doi.org/10.1183/23120541.00565-2021.
  59. Yi S., Ngin C., Tout S., Chhoun P., Fleming T., & Brody C. Utilization of traditional, complementary and alternative medicine and mental health among patients with chronic diseases in primary health care settings in Cambodia. International Journal of Mental Health Systems, 11, (2017), 58. https://doi.org/10.1186/s13033-017-0167-x.
  60. Dağtaş Gülgün C. P., & Kaya H. Complementary and alternative medicine use in lung cancer patients and its impact on the quality of life. Kafkas Journal of Medical Sciences, 5(2), (2015), 41–47. https://dergipark.org.tr/en/pub/kaftbd/issue/35430/393635.
  61. Kanyılmaz G., Akmansu M., Bora H. & Erkal Y. E. The use of complementary and alternative medicine among cancer patients treated with radiotherapy. Turkish Journal of Oncology, 37(1), (2022), 74–82. https://doi.org/10.5505/tjo.2021.3357.
  62. Pleguezuelos E., Carmen Del A., Moreno E., Ortega P., Vila X., Ovejero L., &.Miravitlles M. The experience of COPD patients in lockdown due to the COVID-19 pandemic. International Journal of Chronic Obstructive Pulmonary Disease, 15, (2020), 2621-2627. https://doi.org/10.2147/copd.s268421.
  63. Khadka D., Dhamala K. M., Li F., Aryal P. C., Magar P. R., Bhatta S., &. Cui D. The use of medicinal plants to prevent COVID-19 in Nepal. Journal of Ethnobiology and Ethnomedicine, 26, (2021), 1-17. https://doi.org/10.21203/rs.3.rs-88908/v2.
  64. Tejada-Villena M., Ferchau-Vera I., Cardona-Rivero A., Zamalloa-Cornejo R., Quispe-Florez M., Frisancho-Triveno Z., &.Yanez J. A. Use of medicinal plants for COVID-19 prevention and respiratory symptom treatment during the pandemic in Cusco, Peru: a cross-sectional survey. PLoS One, 16(9), (2021), e0257165. https://doi.org/10.1371/journal.pone.0257165.
  65. Kolakowsky-Hayner S. A., Goldin Y., Kingsley K., Alzueta E., Arango-Lasprilla J. C., Perrin P. B., &.Constantinidou F. Psychosocial impacts of the COVID-19 quarantine: a study of gender differences in 59 countries. Medicina, 57(8), (2021), 789. https://doi.org/10.3390/medicina57080789.
  66. Cori L., Curzio O., Adorni F., Prinelli F., Noale M., Trevisan C., &. Bianchi F. Fear of COVID-19 for individuals and family members: indications from the national cross-sectional study of the EPICOVID19 web-based survey. Int J Environ Res Public Health, 18(6), (2021), 3248. https://doi.org/10.3390/ijerph18063248.
  67. Philip K. E. J., Buttery S., Williams P., Vijayakumar B., Tonkin J., Cumella A., &. Hopkinson N. S. Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey. BMJ Open Respiratory Research, 9(1), (2022), e001056. https://doi.org/10.1136/bmjresp-2021-001056.
  68. Seifert G., Jeitler M., Stange R., Michalsen A., Cramer H., Brinkhaus B., &. Kessler C. S. The relevance of complementary and integrative medicine in the COVID-19 pandemic: a qualitative review of the literature. Frontiers Medicine, 7, (2020), 1-14. https://doi.org/10.3389/fmed.2020.587749.
  69. Anllo H., Herer B., Delignieres A., Ghergan A., Bocahu Y., Segundo I., &. Larue F. Hypnosis for the management of COPD-related anxiety and dyspnoea in pulmonary rehabilitation: rationale and design for a cluster-randomised, active-control trial. ERJ Open Research, 8(1), (2021), 00565-2021. https://doi.org/10.1183/23120541.00565-2021.